NARI Inari Medical, Inc. revenue, earnings and financials
For the quarter ended September 30, 2024, Inari Medical, Inc. reported revenue of $153M (up 21.4% from a year earlier), net income of −$18.4M and diluted EPS of −$0.31; over the last four quarters revenue was $574M and net income −$78.6M; for the fiscal year ended December 2023 revenue was $494M, up 28.7% on the year before.
NARI annual revenue and earnings
- Fiscal year ended Dec 2023: revenue $494M, gross profit $435M, operating income −$14.0M, net income −$1.64M (margin -0.3%), EPS −$0.03
- Fiscal year ended Dec 2022: revenue $383M, gross profit $339M, operating income −$28.1M, net income −$29.3M (margin -7.6%), EPS −$0.55
- Fiscal year ended Dec 2021: revenue $277M, gross profit $252M, operating income $10.8M, net income $9.84M (margin 3.6%), EPS $0.18
NARI quarterly revenue and earnings
- Quarter ended Sep 30, 2024: revenue $153M (up 21.4% year over year), net income −$18.4M, EPS −$0.31
- Quarter ended Jun 30, 2024: revenue $146M (up 22.5% year over year), net income −$31.3M, EPS −$0.54
- Quarter ended Mar 31, 2024: revenue $143M (up 23.3% year over year), net income −$24.2M, EPS −$0.42
- Quarter ended Dec 31, 2023 (from the annual report): revenue $132M (up 22.6% year over year), net income −$4.67M, EPS −$0.08
- Quarter ended Sep 30, 2023: revenue $126M (up 31.4% year over year), net income $3.16M, EPS $0.05
- Quarter ended Jun 30, 2023: revenue $119M (up 28.3% year over year), net income $2.09M, EPS $0.04
- Quarter ended Mar 31, 2023: revenue $116M (up 33.9% year over year), net income −$2.22M, EPS −$0.04
- Quarter ended Dec 31, 2022 (from the annual report): revenue $108M (up 29.5% year over year), net income −$5.80M, EPS −$0.11
- Quarter ended Sep 30, 2022: revenue $96.2M (up 31.9% year over year), net income −$10.2M, EPS −$0.19
- Quarter ended Jun 30, 2022: revenue $92.7M (up 46.2% year over year), net income −$10.2M, EPS −$0.19
- Quarter ended Mar 31, 2022: revenue $86.8M (up 51.1% year over year), net income −$3.13M, EPS −$0.06
- Quarter ended Dec 31, 2021 (from the annual report): revenue $83.2M, net income $1.11M, EPS $0.04
- Quarter ended Sep 30, 2021: revenue $72.9M, net income −$2.80M, EPS −$0.06
- Quarter ended Jun 30, 2021: revenue $63.5M, net income $4.07M, EPS $0.07
- Quarter ended Mar 31, 2021: revenue $57.4M, net income $7.47M, EPS $0.13
NARI cash flow, buybacks and dividends
- Fiscal year ended Dec 2023: operating cash flow $35.9M, share buybacks n/a
- Fiscal year ended Dec 2022: operating cash flow −$14.0M, share buybacks n/a
- Fiscal year ended Dec 2021: operating cash flow $25.5M, share buybacks n/a
NARI balance sheet
- Sep 30, 2024: cash $41.1M, total assets $697M, total liabilities $262M, shareholders' equity $435M
- Jun 30, 2024: cash $70.1M, total assets $673M, total liabilities $249M, shareholders' equity $424M
- Mar 31, 2024: cash $66.7M, total assets $662M, total liabilities $215M, shareholders' equity $447M
- Dec 31, 2023: cash $38.6M, total assets $674M, total liabilities $209M, shareholders' equity $465M
- Sep 30, 2023: cash $89.2M, total assets $549M, total liabilities $96.7M, shareholders' equity $452M
- Jun 30, 2023: cash $57.8M, total assets $525M, total liabilities $89.3M, shareholders' equity $436M
- Mar 31, 2023: cash $56.6M, total assets $507M, total liabilities $79.8M, shareholders' equity $427M
- Dec 31, 2022: cash $60.2M, total assets $504M, total liabilities $87.2M, shareholders' equity $417M
What is NARI's revenue?
Inari Medical, Inc. reported $574M of revenue over its last four quarters, through September 30, 2024.
Is NARI profitable?
No. Inari Medical, Inc. lost $78.6M over the last four quarters.
What is NARI's EPS?
Diluted earnings per share over the last four quarters were −$1.35; −$0.31 in the latest quarter.